Skip to main content
Premium Trial:

Request an Annual Quote

Steven Kafka, Troy Cox, Konstantin Fiedler

Steven Kafka will resign as president and chief operating officer of Foundation Medicine, effective Feb. 16, 2018. CEO Troy Cox will take on the additional role of president, and Konstantin Fiedler will become COO. Fiedler joined the company in 2016 as senior vice president of international markets and managing director of FMI Germany, the firm's wholly-owned subsidiary in Germany. Prior to that, he was head of innovation of the healthcare unit of Linde, and before that, managing director in the Leica Biosystems division of Danaher. Earlier, he was a general manager in General Electric's life sciences division. Fiedler holds a master of science degree in physics from the University of Graz and a PhD in physics from the University of Konstanz.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.